U6-1241P: A Potential Drug Target and Biomarker for Diseases (G106481572)

Target Name: RNU6-1241P

NCBI ID: G106481572

Other Name(s): RNA, U6 small nuclear 1241, pseudogene

U6-1241P: A Potential Drug Target and Biomarker for Diseases

RNA-U6 small nuclear RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression. One of the well-known RNA molecules derived from U6 snRNA is called U6-1241P. This RNA molecule has been identified as a potential drug target and biomarker for various diseases, including cancer.

The U6-1241P RNA molecule is a single-stranded RNA molecule that contains 124 nucleotides. It is expressed in various tissues and cells of the human body, including the brain, heart, liver, and pancreas. U6-1241P has been shown to play a role in the regulation of gene expression and has been associated with various diseases.

One of the key functions of U6-1241P is its role in the regulation of gene expression. U6-1241P is known to interact with various protein factors, including Ku70 and SnRNA28, to regulate the translation of U6 snRNA into a functional RNA molecule. U6-1241P has also been shown to play a role in the regulation of microRNA (miRNA) expression, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation.

In addition to its role in gene expression, U6-1241P has also been shown to play a role in the regulation of RNA stability and quality. U6-1241P has been shown to interact with the protein stability-associated RNA (SAI) complex, which is responsible for the stability of various RNA molecules, including U6 snRNA. This interaction between U6-1241P and SAI suggests that U6-1241P may be a potential drug target or biomarker for diseases associated with unstable RNA molecules.

Another function of U6-1241P is its role in the regulation of cellular signaling pathways. U6-1241P has been shown to interact with various signaling proteins, including the protein kinase Akt. This interaction between U6-1241P and Akt suggests that U6-1241P may be a potential drug target or biomarker for diseases associated with altered cellular signaling pathways.

Furthermore, U6-1241P has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration and invasion. U6-1241P has been shown to interact with various proteins involved in these processes, including the protein ZEB2. This interaction between U6-1241P and ZEB2 suggests that U6-1241P may be a potential drug target or biomarker for diseases associated with altered cellular processes.

In conclusion, U6-1241P is a RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its role in the regulation of gene expression, RNA stability and quality, cellular signaling pathways, and cellular processes suggests that U6-1241P may be a valuable tool for the development of new therapeutic strategies for a variety of diseases. Further research is needed to determine the exact role of U6-1241P in disease progression and to identify potential biomarkers for these diseases.

Protein Name: RNA, U6 Small Nuclear 1241, Pseudogene

More Common Targets